Issues in design, measurement, and analysis for menopause research-Reference-Cited by-同舟云学术

Issues in design, measurement, and analysis for menopause research

Published:1994-05 Issue:3-4 Volume:29 Page:479-493
ISSN:0531-5565
Container-title:Experimental Gerontology
language:en
Short-container-title:Experimental Gerontology

Author:

McKinlay Sonja M.

Publisher

Elsevier BV

Subject

Cell Biology,Endocrinology,Genetics,Molecular Biology,Ageing,Biochemistry

Reference52 articles.

1. Cardiovascular disease and hormone replacement therapy: A pilot case-control study;Adam;Br. Med. J.,1981

2. Use of replacement estrogens and the risk of myocardial infarction;Avila;Epidemiol.,1990

3. Health-care utilization among mid-aged women;Avis;Multidisciplinary Perspectives on Menopause, Ann. NY Acad. Sci.,1990

4. Does hormone replacement therapy protect against coronary heart disease in women? Results of a meta-analysis;Berlin;New England Research Institutes Monograph,1991

5. A prospective study of factors affecting age at menopause;Brambilla;J. Clin. Epidemiol.,1989

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Decline in telomere length by age and effect modification by gender, allostatic load and comorbidities in National Health and Nutrition Examination Survey (1999-2002);PLOS ONE;2019-08-30

2. Patterns of Pharmacological Treatment for Osteoporosis Among Patients Qualified for Pharmacotherapy According to the National Osteoporosis Foundation Guidelines;Annals of Pharmacotherapy;2015-06-03

3. United States Adults Meeting 2010 American College of Rheumatology Criteria for Treatment and Prevention of Glucocorticoid-Induced Osteoporosis;Arthritis Care & Research;2014-10-24

4. Gynaecological Problems Associated with Menopause;Skin, Mucosa and Menopause;2014-09-30

5. The potential impact of the National Osteoporosis Foundation guidance on treatment eligibility in the USA: an update in NHANES 2005–2008;Osteoporosis International;2011-06-30